Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency
NACompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
September 30, 1997
Study Completion Date
March 31, 2000
Conditions
Common Variable Immunodeficiency
Interventions
DRUG
PEG-interleukin-2
All Listed Sponsors
lead
Icahn School of Medicine at Mount Sinai
OTHER
NCT00004695 - Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency | Biotech Hunter | Biotech Hunter